CHEMBIO DIAGNOSTICS, INC. Net Change in Cash
CHEMBIO DIAGNOSTICS, INC. reported Net Change in Cash of -$10.59 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2023-03-29
- CHEMBIO DIAGNOSTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$4.37M.
- CHEMBIO DIAGNOSTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was -$8.72M.
- CHEMBIO DIAGNOSTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-03-31 was -$7.03M.
- CHEMBIO DIAGNOSTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2019-03-31 was -$5.15M.
- CHEMBIO DIAGNOSTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$10.59M, a 285.64% decline from fiscal 2021.
- CHEMBIO DIAGNOSTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $5.71M, a 19.01% increase from fiscal 2020.
- CHEMBIO DIAGNOSTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $4.79M, a 16.56% decline from fiscal 2019.
- CHEMBIO DIAGNOSTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2019 was $5.75M, a 34.20% decline from fiscal 2018.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$10.59M 10-K · filed 2023-03-29 | |||
| 2022-09-30 | -$7.72M 10-Q · filed 2022-11-03 | |||
| 2022-06-30 | -$5.94M 10-Q · filed 2022-08-05 | |||
| 2022-03-31 | -$4.37M 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | $5.71M 10-K · filed 2023-03-29 | |||
| 2021-09-30 | $12.94M 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | -$17.50M 10-Q · filed 2022-08-05 | |||
| 2021-03-31 | -$8.72M 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $4.79M 10-K · filed 2022-03-03 | |||
| 2020-09-30 | $10.42M 10-Q · filed 2021-11-05 | |||
| 2020-06-30 | $18.16M 10-Q · filed 2021-08-09 | |||
| 2020-03-31 | -$7.03M 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $5.75M 10-K · filed 2021-03-11 | |||
| 2019-09-30 | $9.34M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | -$8.02M 10-Q · filed 2020-08-07 | |||
| 2019-03-31 | -$5.15M 10-Q · filed 2020-05-04 | |||
| 2018-12-31 | $8.73M 10-K · filed 2020-03-13 | |||
| 2018-09-30 | $3.06M 10-Q · filed 2019-11-07 | |||
| 2018-06-30 | $5.72M 10-Q · filed 2019-08-06 |